{
  "docId": "019dd923-622c-750b-8b9b-7e7228555e88",
  "docSlug": "36c903ba19aa",
  "documentTitle": "Allergan, Inc. (AGN)",
  "authorId": "01_Pershing_Square",
  "authorName": "William Ackman",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2014-04-22 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.70665085,
  "pageNumber": 102,
  "pageCount": 110,
  "prevPage": 101,
  "nextPage": 103,
  "slideType": "comparison_table",
  "function": "compare_peers",
  "density": "sparse",
  "nDataPoints": 0,
  "notes": "The slide uses a contrast-pair structure to highlight the perceived reliability of Valeant's synergy track record versus the uncertainty of standalone Allergan's growth drivers.",
  "elementsJson": [
    "headline_text",
    "callout_box"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9b-7e7228555e88/102",
  "deckHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-7e7228555e88#slide-102",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.4,
        "x": 0.5,
        "y": 0.37
      },
      "kind": "callout",
      "text": "Valeant has achieved announced cost synergies in all announced transactions",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "597173e3-5cca-4142-b0e0-5de8bc5c9032",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.4,
        "x": 0.5,
        "y": 0.22
      },
      "kind": "callout",
      "text": "Mixed track record",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "632fb5c1-cd37-4c16-9ed1-526f82009a53",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.4,
        "x": 0.5,
        "y": 0.47
      },
      "kind": "callout",
      "text": "Upside",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a596f2e6-0fb2-418b-8732-9ed2dc0ddff7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.8,
        "x": 0.1,
        "y": 0.15
      },
      "kind": "list",
      "text": "Allergan 'Standalone' Sources of Incremental Value: M&A, R&D Success, Cost Savings. Transaction Sources of Value: Cost Synergies, Organic Growth, Business Development.",
      "attrs": null,
      "subkind": "comparison",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "516eaad0-ce57-407e-9460-75bb9e2fcad1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.45,
        "x": 0.09,
        "y": 0.09
      },
      "kind": "title",
      "text": "Standalone Allergan vs. Val-gan",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "edf5a9a5-94af-404a-8e1a-c5b3780343eb",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "comparison-frame",
      "slug": null,
      "matchId": "73f4784b-dbf2-4d7b-8028-19d5f66f8e5a",
      "evidence": "Direct comparison of two strategic paths using contrasting value drivers.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}